The insulin-like growth factor I receptor regulates glucose transport by astrocytes

GLIA

Volumn 64, Issue 11, 2016, Pages 1962-1971

  Hernandez Garzón, Edwin ^a,b   Fernandez, Ana M ^a,b   Perez Alvarez, Alberto ^a,c   Genis, Laura ^a,b   Bascuñana, Pablo ^d   Fernandez de la Rosa, Ruben ^d   Delgado, Mercedes ^d   Angel Pozo, Miguel ^d   Moreno, Estefania ^b,e   McCormick, Peter J ^b,e,f   Santi, Andrea ^a,b   Trueba Saiz, Angel ^a,b   Garcia Caceres, Cristina ^g   Tschöp, Matthias H ^g   Araque, Alfonso ^a   Martin, Eduardo D ^h   Torres Aleman, Ignacio ^a,b  

^a INSTITUTO CAJAL   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^e UNIVERSITY OF BARCELONA   (Spain)

^f UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^g Institute for Diabetes and Obesity   (Germany)

^h UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

Author keywords

astrocytes; glucose metabolism; glucose transporter 1; insulin like growth factor I receptor

Indexed keywords

CELL SURFACE PROTEIN; FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER 1; SCAFFOLD PROTEIN; SHORT HAIRPIN RNA; SOMATOMEDIN C RECEPTOR;

ADULT; ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; BIOTINYLATION; CONFOCAL LASER SCANNING MICROSCOPY; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; INTRAVITAL MICROSCOPY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SENSORY STIMULATION; SOMATOSENSORY CORTEX; VESICULOVIRUS;

EID: 84990848562     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.23035     Document Type: Article

References (50)

1. Allaman I, Belanger M, Magistretti PJ. 2011. Astrocyte-neuron metabolic relationships: For better and for worse. Trends Neurosci 34:76–87.
2. Barnes K, Ingram JC, Porras OH, Barros LF, Hudson ER, Fryer LG, Foufelle F, Carling D, Hardie DG, Baldwin SA. 2002. Activation of GLUT1 by metabolic and osmotic stress: Potential involvement of AMP-activated protein kinase (AMPK). J Cell Sci 115:2433–2442.
3. Barros LF, Bittner CX, Loaiza A, Ruminot I, Larenas V, Moldenhauer H, Oyarzun C, Alvarez M. 2009a. Kinetic validation of 6-NBDG as a probe for the glucose transporter GLUT1 in astrocytes. J Neurochem 109 Suppl 1:94–100.
4. Barros LF, Courjaret R, Jakoby P, Loaiza A, Lohr C, Deitmer JW. 2009b. Preferential transport and metabolism of glucose in Bergmann glia over Purkinje cells: A multiphoton study of cerebellar slices. Glia 57:962–970.
5. Biondi O, Branchu J, Ben Salah A, Houdebine L, ertin L, Chali F, Desseille C, eill L, Sanchez G, Lancelin C, et al. 2015. IGF-1R reduction triggers neuroprotective signaling pathways in spinal muscular atrophy mice. J Neurosci 35:12063–12079.
6. Booth RA, Cummings C, Tiberi M, Liu XJ. 2002. GIPC participates in G protein signaling downstream of insulin-like growth factor 1 receptor. J Biol Chem 277:6719–6725.
7. Boucher J, Macotela Y, Bezy O, Mori MA, Kriauciunas K, Kahn CR. 2010. A kinase-independent role for unoccupied insulin and IGF-1 receptors in the control of apoptosis. Sci Signal 3:ra87-
8. Bunn RC, Jensen MA, Reed BC. 1999. Protein interactions with the glucose transporter binding protein GLUT1CBP that provide a link between GLUT1 and the cytoskeleton. Mol Biol Cell 10:819–832.
9. Carro E, Spuch C, Trejo JL, Antequera D, Torres-Aleman I. 2005. Choroid plexus megalin is involved in neuroprotection by serum insulin-like growth factor I. J Neurosci 25:10884–10893.
10. Cohen E, Dillin A. 2008. The insulin paradox: Aging, proteotoxicity and neurodegeneration. Nat Rev Neurosci 9:759–767.
11. Cohen E, Paulsson JF, Blinder P, Burstyn-Cohen T, Du D, Estepa G, Adame A, Pham HM, Holzenberger M, Kelly JW, et al. 2009. Reduced IGF-1 signaling delays age-associated proteotoxicity in mice. Cell 139:1157–1169.
12. Chuquet J, Quilichini P, Nimchinsky EA, Buzsaki G. 2010. Predominant enhancement of glucose uptake in astrocytes versus neurons during activation of the somatosensory cortex. J Neurosci 30:15298–15303.
13. De Magalhaes Filho CD, Kappeler L, Dupont J, Solinc J, Villapol S, Denis C, Nosten-Bertrand M, Billard JM, Blaise A, Tronche F, et al. 2016. Deleting IGF-1 receptor from forebrain neurons confers neuroprotection during stroke and upregulates endocrine somatotropin. J Cereb Blood Flow Metab Pub ahead (accession number: 10.1177/0271678X15626718).
14. Dringen R, Hamprecht B. 1992. Glucose, insulin, and insulin-like growth factor I regulate the glycogen content of astroglia-rich primary cultures. J Neurochem 58:511–517.
15. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L. 1998. A third-generation lentivirus vector with a conditional packaging system. J Virol 72:8463–8471.
16. Fernandez AM, Fernandez S, Carrero P, Garcia-Garcia M, Torres-Aleman I. 2007. Calcineurin in reactive astrocytes plays a key role in the interplay between proinflammatory and anti-inflammatory signals. J Neurosci 27:8745–8756.
17. Fernandez AM, Torres-Aleman I. 2012. The many faces of insulin-like peptide signalling in the brain. Nat Rev Neurosci 13:225–239.
18. Gazit N, Vertkin I, Shapira I, Helm M, Slomowitz E, Sheiba M, Mor Y, Rizzoli S, Slutsky I. 2016. IGF-1 receptor differentially regulates spontaneous and evoked transmission via mitochondria at hippocampal synapses. Neuron 89:1–15.
19. Gontier G, George C, Chaker Z, Holzenberger M, Aid S. 2015. Blocking IGF signaling in adult neurons alleviates Alzheimer's disease pathology through amyloid-beta clearance. J Neurosci 35:11500–11513.
20. Gonzalez S, Moreno-Delgado D, Moreno E, Perez-Capote K, Franco R, Mallol J, Cortes A, Casado V, Lluis C, Ortiz J, et al. 2012. Circadian-related heteromerization of adrenergic and dopamine D(4) receptors modulates melatonin synthesis and release in the pineal gland. PLoS Biol 10:e1001347-
21. Hamai M, Minokoshi Y, Shimazu T. 1999. L-Glutamate and insulin enhance glycogen synthesis in cultured astrocytes from the rat brain through different intracellular mechanisms. J Neurochem 73:400–407.
22. Jakoby P, Schmidt E, Ruminot I, Gutierrez R, Barros LF, Deitmer JW. 2014. Higher transport and metabolism of glucose in astrocytes compared with neurons: A multiphoton study of hippocampal and cerebellar tissue slices. Cereb Cortex 24:222–231.
23. Kappeler L, Filho CDM, Dupont J, Leneuve P, Cervera P, Périn L, Loudes C, Blaise A, Klein R, Epelbaum J and others 2008. Brain IGF-1 Receptors Control Mammalian Growth and Lifespan through a Neuroendocrine Mechanism. PLoS Biol 6:e254.
24. Katoh M. 2013. Functional proteomics, human genetics and cancer biology of GIPC family members. Exp Mol Med 45:e26.
25. Kenyon CJ. 2010. The genetics of ageing. Nature 464:504–512.
26. Koshy S, Alizadeh P, Timchenko LT, Beeton C. 2010. Quantitative measurement of GLUT4 translocation to the plasma membrane by flow cytometr. J Vis Exp 2429- pii.
27. Kum W, Zhu SQ, Ho SK, Young JD, Cockram CS. 1992. Effect of insulin on glucose and glycogen metabolism and leucine incorporation into protein in cultured mouse astrocytes. Glia 6:264–268.
28. Kuntner C, Kesner AL, Bauer M, Kremslehner R, Wanek T, Mandler M, Karch R, Stanek J, Wolf T, Muller M, et al. 2009. Limitations of small animal PET imaging with [18F]FDDNP and FDG for quantitative studies in a transgenic mouse model of Alzheimer's disease. Mol Imaging Biol 11:236–240.
29. La Joie R, Perrotin A, Barros L, Hommet C, Mazenge F, Ibazizene M, Camus V, Abbas A, Landeau B, Guilloteau D, et al. 2012. Region-specific hierarchy between atrophy, hypometabolism, and beta-amyloid (abeta) load in Alzheimer's disease dementia. J Neurosci 32:16265–16273.
30. Ligensa T, Krauss S, Demuth D, Schumacher R, Camonis J, Jaques G, Weidner KM. 2001. A PDZ domain protein interacts with the C-terminal tail of the insulin-like growth factor-1 receptor but not with the insulin receptor. J Biol Chem 276:33419–33427.
31. Liu CC, Hu J, Tsai CW, Yue M, Melrose HL, Kanekiyo T, Bu G. 2015. Neuronal LRP1 regulates glucose metabolism and insulin signaling in the brain. J Neurosci 35:5851–5859.
32. Loaiza A, Porras OH, Barros LF. 2003. Glutamate triggers rapid glucose transport stimulation in astrocytes as evidenced by real-time confocal microscopy. J Neurosci 23:7337–7342.
33. Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. 2013. The hallmarks of aging. Cell 153:1194–1217.
34. Masters BA, Werner H, Roberts CT Jr, LeRoith D, Raizada MK. 1991. Developmental regulation of insulin-like growth factor-I-stimulated glucose transporter in rat brain astrocytes. Endocrinology 128:2548–2557.
35. Mathiisen TM, Lehre KP, Danbolt NC, Ottersen OP. 2010. The perivascular astroglial sheath provides a complete covering of the brain microvessels: An electron microscopic 3D reconstruction. Glia 58:1094–1103.
36. Matsunaga Y, Gengyo-Ando K, Mitani S, Iwasaki T, Kawano T. 2012. Physiological function, expression pattern, and transcriptional regulation of a Caenorhabditis elegans insulin-like peptide, INS-18. Biochem Biophys Res Commun 423:478–483.
37. Mergenthaler P, Lindauer U, Dienel GA, Meisel A. 2013. Sugar for the brain: The role of glucose in physiological and pathological brain function. Trends Neurosci 36:587–597.
38. Morgello S, Uson RR, Schwartz EJ, Haber RS. 1995. The human blood-brain barrier glucose transporter (GLUT1) is a glucose transporter of gray matter astrocytes. Glia 14:43–54.
39. Muhic M, Vardjan N, Chowdhury HH, Zorec R, Kreft M. 2015. Insulin and insulin-like growth factor 1 (IGF-1) modulate cytoplasmic glucose and glycogen levels but not glucose transport across the membrane in astrocytes. J Biol Chem 290:11167–11176.
40. Munive V, Santi A, Torres-Aleman I. 2016. A concerted action of estradiol and insulin like growth factor I underlies sex differences in mood regulation by exercise. Sci Rep 6:25969-
41. Nimmerjahn A, Kirchhoff F, Kerr JN, Helmchen F. 2004. Sulforhodamine 101 as a specific marker of astroglia in the neocortex in vivo. Nat Methods 1:31–37.
42. Nishijima T, Piriz J, Duflot S, Fernandez AM, Gaitan G, Gomez-Pinedo U, Verdugo JM, Leroy F, Soya H, Nunez A, et al. 2010. Neuronal activity drives localized blood-brain-barrier transport of serum insulin-like growth factor-I into the CNS. Neuron 67:834–846.
43. O'Neill C, Kiely AP, Coakley MF, Manning S, Long-Smith CM. 2012. Insulin and IGF-1 signalling: longevity, protein homoeostasis and Alzheimer's disease. Biochem Soc Trans 407:721–727.
44. Perez-Alvarez A, Araque A, Martin ED. 2013. Confocal microscopy for astrocyte in vivo imaging: Recycle and reuse in microscopy. Front Cell Neurosci 7:51-
45. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45-
46. Porras OH, Ruminot I, Loaiza A, Barros LF. 2008. Na(+)-Ca(2+) cosignaling in the stimulation of the glucose transporter GLUT1 in cultured astrocytes. Glia 56:59–68.
47. Roy CS, Sherrington C. 1890. On the regulation of the blood supply of the brain. J Physiol 11:85–108.
48. Vilchez D, Saez I, Dillin A. 2014. The role of protein clearance mechanisms in organismal ageing and age-related diseases. Nat Commun 5:5659
49. Wieman HL, Wofford JA, Rathmell JC. 2007. Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking. Mol Biol Cell 18:1437–1446.
50. Winkler EA, Nishida Y, Sagare AP, Rege SV, Bell RD, Perlmutter D, Sengillo JD, Hillman S, Kong P, Nelson AR, et al. 2015. GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration. Nat Neurosci 18:521–530.